Anvisa approved the registration of a new generic whose substances still has no competitor in the market. This is the record of deferasirox dispersible tablet, which is used to remove excess iron from the body. Is used to treat iron overload caused by repeated blood transfusions. With the approval, patients and doctors will have a new treatment option at a more affordable cost, since generics come to market with a price less than the price of medicines.
GiroNews – 23/07/2015
Related products
News Item translated automatically
Click HERE to see original